Teachers Retirement System of The State of Kentucky Sells 390 Shares of Masimo Co. (NASDAQ:MASI)

Teachers Retirement System of The State of Kentucky lessened its stake in Masimo Co. (NASDAQ:MASI) by 2.5% in the third quarter, HoldingsChannel reports. The fund owned 15,451 shares of the medical equipment provider’s stock after selling 390 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Masimo were worth $2,060,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of MASI. Edgestream Partners L.P. bought a new stake in Masimo in the 2nd quarter worth $645,000. Simplify Asset Management Inc. boosted its holdings in shares of Masimo by 120.4% during the second quarter. Simplify Asset Management Inc. now owns 21,670 shares of the medical equipment provider’s stock worth $2,729,000 after purchasing an additional 11,838 shares during the period. ING Groep NV grew its stake in shares of Masimo by 143.3% in the third quarter. ING Groep NV now owns 240,900 shares of the medical equipment provider’s stock worth $32,119,000 after purchasing an additional 141,900 shares during the last quarter. Westfield Capital Management Co. LP increased its holdings in Masimo by 23.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,394,056 shares of the medical equipment provider’s stock valued at $185,869,000 after purchasing an additional 262,370 shares during the period. Finally, Thrivent Financial for Lutherans raised its position in Masimo by 42.1% during the 2nd quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment provider’s stock valued at $153,314,000 after purchasing an additional 360,497 shares during the last quarter. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Piper Sandler lifted their price objective on Masimo from $165.00 to $180.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. BTIG Research lifted their price target on shares of Masimo from $166.00 to $170.00 and gave the company a “buy” rating in a report on Monday, October 14th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Wednesday, November 6th. Wells Fargo & Company lifted their target price on shares of Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Finally, Raymond James raised shares of Masimo from a “market perform” rating to an “outperform” rating and set a $170.00 price target for the company in a research note on Wednesday, November 6th. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, Masimo currently has an average rating of “Moderate Buy” and an average target price of $170.67.

Masimo Stock Up 0.6 %

NASDAQ:MASI opened at $177.26 on Tuesday. Masimo Co. has a 1-year low of $101.61 and a 1-year high of $180.97. The company has a market capitalization of $9.49 billion, a PE ratio of 122.68 and a beta of 1.01. The firm’s 50-day moving average price is $157.26 and its 200-day moving average price is $133.23. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11.

Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.14. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The business had revenue of $504.60 million for the quarter, compared to analysts’ expectations of $502.87 million. During the same quarter in the prior year, the company earned $0.63 earnings per share. The business’s revenue was up 5.4% compared to the same quarter last year. On average, equities analysts predict that Masimo Co. will post 4.03 EPS for the current fiscal year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.